Top Medical Stocks To Own For 2019

The marijuana industry is growing by leaps and bounds in North America. Cannabis research firm ArcView, in partnership with BDS Analytics, found that legal pot sales soared 33% in 2017 to $9.7 billion. A decade from now, ArcView sees North American sales topping an estimated $47 billion.

This impressive growth is due to a combination of state- and country-level expansion, as well as a general shift in the way people perceive cannabis.

Regarding the former, Mexico legalized medical marijuana in June 2017, 29 U.S. states have legalized cannabis in some capacity since 1996, and Canada appears to be on the verge of passing the Cannabis Act, which would make it the first developed country in the world to have legalized adult-use marijuana. As expansion continues, sales for growers and ancillary pot industry businesses are expected to soar.

Image source: Getty Images.

Top Medical Stocks To Own For 2019: Cognizant Technology Solutions Corporation(CTSH)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Oil prices are at levels we haven’t seen in years. U.S. crude topped $70 for the first since 2014, as U.S. President Donald Trump appeared increasingly likely to pull out of the Iran nuclear deal and reinforce sanctions on Tehran. In addition, OPEC has announced plans to bolster prices and cap production. For oil investors, Money MorningGlobal Energy Strategist Dr. Kent Moors says it’s time to buckle up. According to Moors, revoking the Iran deal would cause “price chaos” around the globe. And that’s right as driving season starts in the United States. Here’s more on the coming chaos for oil. In deal news, Blackstone Group (NYSE: BX) announced it will purchase Gramercy Property Trust (NYSE: GPT) for $7.6 billion in cash. Grammercy manages commercial real estate. While this may seem like a boring deal, Blackstone is buying a business that churns out cold hard cash for its investors. We want to keep this deal on your radar, because there are many other deals like this coming down the pipeline. We’re going to be discussing one of the best real estate opportunities available very soon – so keep an eye out for updates.
    Three Stocks to Watch Today: AMZN, AAPL, TSN, SBUX
    Shareholders of Inc. (Nasdaq: AMZN) cheered statements made by Warren Buffett over the weekend. The Oracle of Omaha said he messed up by not investing in Amazon and Alphabet Inc. (Nasdaq: GOOGL). “I made the wrong decisions on Google and Amazon,” Buffett said on Saturday. “We’ve looked at it. I made the mistake in not being able to come to a conclusion where I really felt that at the present prices that the prospects were far better than the prices indicated.” Buffett says he now has a “very, very, very high opinion” of Amazon CEO Jeff Bezos. The Oracle believes that Bezos has created something that is “close to a miracle.” Apple Inc. (Nasdaq: AAPL) added another 0.6% Monday, to reach $185.00 per share – a new 52-week high. The uptick came after Warren Buffett announced

  • [By Logan Wallace]

    Highland Capital Management LP increased its position in Cognizant Technology Solutions Corp (NASDAQ:CTSH) by 49.3% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 162,000 shares of the information technology service provider’s stock after purchasing an additional 53,500 shares during the period. Highland Capital Management LP’s holdings in Cognizant Technology Solutions were worth $13,041,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    State Board of Administration of Florida Retirement System lowered its holdings in shares of Cognizant (NASDAQ:CTSH) by 1.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 837,118 shares of the information technology service provider’s stock after selling 11,877 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in Cognizant were worth $67,388,000 at the end of the most recent reporting period.

Top Medical Stocks To Own For 2019: CBRE Clarion Global Real Estate Income Fund(IGR)

Advisors’ Opinion:

  • [By ]

    CBRE Clarion Global Real Estate Income Fund (NYSE: IGR)
    A long time StreetAuthority staple, mainly in the Daily Paycheck portfolio, IGR is considered a core real estate fund. As the “global” in its name implies, the fund takes a broad approach, with just 41% of the fund’s holdings allocated to U.S. REITs. Property-type diversification is also broad with just a 24% allocation to the worrisome retail sector. Shares trade at a nearly 12% discount to their net asset value (NAV) at around $7.80 with a yield approaching 7.7%.

Top Medical Stocks To Own For 2019: BioDelivery Sciences International Inc.(BDSI)

Advisors’ Opinion:

  • [By Logan Wallace]

    BioDelivery Sciences International (NASDAQ:BDSI) had its target price reduced by research analysts at HC Wainwright from $4.00 to $3.50 in a research report issued to clients and investors on Wednesday. The brokerage currently has a “buy” rating on the specialty pharmaceutical company’s stock. HC Wainwright’s price objective points to a potential upside of 40.00% from the company’s current price.

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares climbed 154.95 percent to close at $5.15 on Thursday. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Tyme Technologies, Inc. (NASDAQ: TYME) jumped 33.45 percent to close at $3.87.
    Universal Corporation (NYSE: UVV) gained 29.72 percent to close at $62.85 after reporting fiscal Q4 results.
    Evolus, Inc. (NASDAQ: EOLS) shares rose 22.93 percent to close at $23.80.
    nLIGHT, Inc. (NASDAQ: LASR) jumped 21.52 percent to close at $36.37 following Q1 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) gained 20.28 percent to close at $2.61.
    The Cato Corporation (NYSE: CATO) shares rose 19.57 percent to close at $21.45 after the company posted better-than-expected first-quarter results.
    AXT, Inc. (NASDAQ: AXTI) gained 18.8 percent to close at $7.90.
    Catasys, Inc. (NASDAQ: CATS) rose 16.33 percent to close at $6.41.
    HUYA Inc. (NYSE: HUYA) rose 15.68 percent to close at $23.09 on Thursday.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) climbed 15.11 percent to close at $6.02 on Thursday after gaining 6.30 percent on Wednesday. Baird initiated coverage on Marinus Pharmaceuticals with an Outperform rating.
    Destination Maternity Corporation (NASDAQ: DEST) shares rose 14.48 percent to close at $3.32 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    China Rapid Finance Limited (NYSE: XRF) gained 11.53 percent to close at $3.29 after announcing preliminary Q1 results.
    Bilibili Inc.. (NASDAQ: BILI) shares rose 11.33 pe
  • [By Stephan Byrd]

    Media headlines about BioDelivery Sciences International (NASDAQ:BDSI) have been trending somewhat positive recently, according to Accern Sentiment. The research firm identifies positive and negative media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. BioDelivery Sciences International earned a news sentiment score of 0.16 on Accern’s scale. Accern also assigned media headlines about the specialty pharmaceutical company an impact score of 46.960149735727 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Lisa Levin]

    BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares were also up, gaining 19 percent to $2.3272 after the company announced board restructuring plan and $50m equity financing deal led by Broadfin to "significantly strengthen" financial position.

Top Medical Stocks To Own For 2019: Apollo Gold Corporation(BRD)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Bread (CURRENCY:BRD) traded 10.1% lower against the U.S. dollar during the 24-hour period ending at 15:00 PM ET on May 6th. Bread has a market cap of $73.13 million and approximately $1.09 million worth of Bread was traded on exchanges in the last 24 hours. One Bread token can currently be purchased for about $0.82 or 0.00008683 BTC on popular exchanges including OKEx, Binance and Cobinhood. In the last seven days, Bread has traded 3.3% higher against the U.S. dollar.

  • [By Joseph Griffin]

    Bread (CURRENCY:BRD) traded 2.1% lower against the U.S. dollar during the 24-hour period ending at 21:00 PM Eastern on May 27th. One Bread token can currently be bought for $0.46 or 0.00006320 BTC on popular cryptocurrency exchanges including Cobinhood, Binance and OKEx. Bread has a market capitalization of $40.78 million and $4.40 million worth of Bread was traded on exchanges in the last day. During the last seven days, Bread has traded down 28.2% against the U.S. dollar.

Top Medical Stocks To Own For 2019: Cambrex Corporation(CBM)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    Cambrex Corp. (NYSE: CBM) was founded in 1981 and is a leading supplier of generic active pharmaceutical ingredients (APIs).

    Cambrex has more than 100 generic APIs, and 90 of them are commercially sold.

Top Medical Stocks To Own For 2019: HCP, Inc.(HCP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    HCP (NYSE:HCP) had its price objective reduced by Morgan Stanley from $28.00 to $23.50 in a research report issued to clients and investors on Thursday. The brokerage presently has an “equal weight” rating on the real estate investment trust’s stock. Morgan Stanley’s price objective indicates a potential downside of 2.16% from the stock’s current price.

  • [By Nelson Hem]

    In "Raymond James Picks Welltower, Sabra Health In Underweighted Health Care REIT Sector," Shanthi Rexaline takes a look at why HCP, Inc. (NYSE: HCP) didn't make the cut among these health care REIT picks.

  • [By Reuben Gregg Brewer]

    An aging baby boomer population is set to boost results at HCP, Inc. (NYSE:HCP) andUniversal Health Services, Inc. (NYSE:UHS) for years to come. But is it better to own physical assets, like real estate investment trust HCP, or run them, like health facility operator Universal? In the end, these two companies are very similar but also differ in many ways. Here’s what you need to know to pick the one that’s right for you.

  • [By Ethan Ryder]

    Swiss National Bank decreased its position in shares of HCP, Inc. (NYSE:HCP) by 13.1% in the first quarter, Holdings Channel reports. The fund owned 1,499,221 shares of the real estate investment trust’s stock after selling 226,400 shares during the quarter. Swiss National Bank’s holdings in HCP were worth $34,827,000 as of its most recent SEC filing.

Leave a Reply

Your email address will not be published. Required fields are marked *